When it comes to cancer, knowledge is power, especially when it comes to screenings and prevention. In this segment, ...

Ovarian cancer standard of care has not advanced in over 30 years, but a new DNA-based immunotherapy could be a gamechanger, ...

Analysis of data from over 1.2 million US patients with gynecologic cancers between 2004 and 2020 revealed a significant shift towards surgical de-escalation, with increased use of minimally invasive ...

The investigational cortisol modulator relacorilant plus nab-paclitaxel improved survival in platinum-resistant ovarian ...

Several drug classes, including immunotherapy, antibody-drug conjugates and PARP inhibitors have helped improve outcomes for gynecologic cancers. Over the past 10 years, PARP inhibitors, immunotherapy ...

While there's no specific screening test for endometrial cancer, awareness and genetic profiles of the tumors are saving ...

“These are frequently lethal cancers if they’re found later on,” said Dr. J. Brian Szender, chief of Surgery at Methodist Stone Oak, he also the Gynecologic Oncology Program Director at the START ...

Approximately 100,000 women are diagnosed with gynecologic cancer every year in the United States. Cancer of the endometrium, or the lining of the uterus, is the most common cancer of a woman’s ...

ALBANY, N.Y. (NEWS10) – September is Gynecologic Cancer Awareness month. The goal is to educate women about these cancers and to promote early detection through screenings with the hope that it will ...

Sofetabart mipitecan received FDA breakthrough therapy designation for platinum-resistant ovarian cancer after prior ...

Qatar Cancer Society (QCS) has concluded its awareness campaign Together for Her, which targeted women across Qatari society as part ...

BUFFALO, N.Y. — Buffalo is one of six cities that have a branch of Pink Ribbon Good (PRG). Pink Ribbon Good is an organization who's mission is assisting those with Brest and Gynecological cancer.